title: Chronic parvovirus B19 infection leading to red cell aplasia following treatment of Hodgkin lymphoma.
authors.affiliation: Department of Haematology, Taunton and Somerset NHS Foundation Trust, UK. sarah.poplar@hotmail.co.uk <sarah.poplar@hotmail.co.uk>
authors.forename: Sarah
authors.initials: S
authors.lastname: Poplar
authors.forename: Sarah
authors.initials: S
authors.lastname: Allford
authors.forename: Nicholas
authors.initials: N
authors.lastname: Rooney
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols; D002908:Chronic Disease; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D010322:Parvoviridae Infections / Q000209:etiology* / Q000628:therapy; D016732:Parvovirus B19, Human / Q000302:isolation & purification*; D016133:Polymerase Chain Reaction; D012010:Red-Cell Aplasia, Pure / Q000628:therapy / Q000821:virology*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D016756:Immunoglobulins, Intravenous